JOURNAL ARTICLE
Add like
Add dislike
Add to saved papers

Decreased immunoreactive inhibin and increased FSH levels in cryptorchidism after orchidopexy.

Endocrine Journal 1995 August
The blood FSH level is often high in patients with severe testicular disorders including cryptorchids. To examine whether inhibin is involved in the increase in FSH we measured immunoreactive inhibin, FSH, LH, and testosterone in 17 patients after orchidopexy. FSH was extremely high (20 mIU/ml or above) in 3 patients. The inhibin level was significantly lower (P < 0.01) in these 3 patients (6.47 +/- 2.19 IU/ml; mean +/- SEM) than in the other 14 patients (14.31 +/- 3.96 IU/ml). All 3 high-FSH patients had azoospermia. Testosterone and LH were normal in one of them. Even considering problems involved in the inhibin assay, the high FSH levels are considered to reflect reductions in the blood inhibin level due to Sertoli cell dysfunction. These findings suggest that inhibin plays an important role in the suppression of FSH at least in some patients after orchidopexy.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app